Over the past weeks, specialists of the Center’s HTA Department conducted three seminars on the new Guideline on State HTA. Among those who gained comprehensive new knowledge on the topic “HTA as a Tool for Assessing the Value of a Medical Technology” were the teams of the pharmaceutical companies “AstraZeneca Ukraine” and “Roche Ukraine”.
The seminars were conducted by Oresta Piniazhko, Director of the HTA Department; Alona Masheiko, Head of the Division for Economic Efficiency Assessment of Medicinal Products; Iryna Romanenko, Head of the Division for Clinical Efficacy Assessment of Medicinal Products; and experts Marharyta Khmelovska and Valeriia Serediuk.
We thank our partners for their active participation in the seminars. The HTA Department will remain open to communication and will continue training activities for all interested parties.
